Skip to main content
OpenTrials

Clinical trial condition

Hepatitis

Explore clinical trials studying Hepatitis. Study availability and eligibility vary by location and protocol.

2,967 public trials 189 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis trial results

Completed

Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients

NCT01131065

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations
  • A.O.U. Policlinico Università di Modena e Reggio Emilia Modena, Italy
  • Az. Ospedaliera Universitaria di Padova Padova, Italy
  • Azienda Ospedaliero Universitaria Pisana Pisa, Italy
  • Az. Ospedaliera S.Giovanni Battista di Torino Torino, Italy
View Trial Details
Completed

Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus

NCT01500265

Conditions
Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations
  • CHU d'Amiens Amiens, France
  • CHU d'Angers Angers, France
  • CHU de Besancon Besançon, France
  • CHU de Bordeaux - Hôpital Saint André Bordeaux, France
View all 25 locations
View Trial Details
Completed

Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4

NCT01686789

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus, +15 more
Locations
  • King Faisal Specialist Hospital & Research Centre Riyadh, Saudi Arabia
  • King Abdulaziz Medical City Riyadh, Saudi Arabia
  • King Khaled University Hospital Riyadh, Saudi Arabia
View Trial Details
Completed

ACCELERATE Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C (CHC) Infection.

NCT00077636

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Birmingham, Alabama, United States
  • Mobile, Alabama, United States
  • Anchorage, Alaska, United States
  • Phoenix, Arizona, United States
View all 132 locations
View Trial Details

Related conditions